No quarterly revenue total was found in Canopy Growth Corp's SEC filings.
Canopy Growth Corp (CGC) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
423.04M
+0.2% vs prior quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CGC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Smith Falls, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1737927
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 16, 2026 | Oct 14, 2026 |
| ARS | Annual report to shareholders | Aug 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Auditor change
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
All 763 Canopy Growth Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.